Cargando…

Metatranscriptome analysis in human papillomavirus negative cervical cancers

Human papillomavirus (HPV) negative cancers are associated with symptomatic detection, late-stage diagnosis, and worse prognosis. It is thus essential to investigate all possible infectious agents and biomarkers that could early identify these HPV negative cancers. We aimed to analyze and compare th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ure, Agustin Enrique, Lagheden, Camilla, Arroyo Mühr, Laila Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445079/
https://www.ncbi.nlm.nih.gov/pubmed/36064569
http://dx.doi.org/10.1038/s41598-022-19008-8
_version_ 1784783347297288192
author Ure, Agustin Enrique
Lagheden, Camilla
Arroyo Mühr, Laila Sara
author_facet Ure, Agustin Enrique
Lagheden, Camilla
Arroyo Mühr, Laila Sara
author_sort Ure, Agustin Enrique
collection PubMed
description Human papillomavirus (HPV) negative cancers are associated with symptomatic detection, late-stage diagnosis, and worse prognosis. It is thus essential to investigate all possible infectious agents and biomarkers that could early identify these HPV negative cancers. We aimed to analyze and compare the metatranscriptome present in HPV positive and HPV negative cervical cancers. We analyzed the whole RNA sequencing files from 223 HPV negative cervical cancers (negativity established after confirming cervical cancer diagnosis, sample adequacy and subjecting specimens to PCR and unbiased RNA sequencing), 223 HPV positive tumors and 11 blank paraffin block pools (used as controls) using Kraken2 software. Overall, 84 bacterial genera were detected, with 6/84 genera showing a positive median number of reads/sample and being present in both cervical tumor groups (HPV positive and negative). Viral reads belonged to 63 different viral genera, with 6/63 genera showing a positive median annotated read/sample value. No significant difference among genera was detected except for the presence of alpha-papillomaviruses. Metatranscriptome of bacteria and viruses present in HPV positive and HPV negative cervical cancers show no significant difference, except for HPV. Further studies are needed to early identify this biologically distinct group of cervical cancers.
format Online
Article
Text
id pubmed-9445079
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-94450792022-09-07 Metatranscriptome analysis in human papillomavirus negative cervical cancers Ure, Agustin Enrique Lagheden, Camilla Arroyo Mühr, Laila Sara Sci Rep Article Human papillomavirus (HPV) negative cancers are associated with symptomatic detection, late-stage diagnosis, and worse prognosis. It is thus essential to investigate all possible infectious agents and biomarkers that could early identify these HPV negative cancers. We aimed to analyze and compare the metatranscriptome present in HPV positive and HPV negative cervical cancers. We analyzed the whole RNA sequencing files from 223 HPV negative cervical cancers (negativity established after confirming cervical cancer diagnosis, sample adequacy and subjecting specimens to PCR and unbiased RNA sequencing), 223 HPV positive tumors and 11 blank paraffin block pools (used as controls) using Kraken2 software. Overall, 84 bacterial genera were detected, with 6/84 genera showing a positive median number of reads/sample and being present in both cervical tumor groups (HPV positive and negative). Viral reads belonged to 63 different viral genera, with 6/63 genera showing a positive median annotated read/sample value. No significant difference among genera was detected except for the presence of alpha-papillomaviruses. Metatranscriptome of bacteria and viruses present in HPV positive and HPV negative cervical cancers show no significant difference, except for HPV. Further studies are needed to early identify this biologically distinct group of cervical cancers. Nature Publishing Group UK 2022-09-05 /pmc/articles/PMC9445079/ /pubmed/36064569 http://dx.doi.org/10.1038/s41598-022-19008-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Ure, Agustin Enrique
Lagheden, Camilla
Arroyo Mühr, Laila Sara
Metatranscriptome analysis in human papillomavirus negative cervical cancers
title Metatranscriptome analysis in human papillomavirus negative cervical cancers
title_full Metatranscriptome analysis in human papillomavirus negative cervical cancers
title_fullStr Metatranscriptome analysis in human papillomavirus negative cervical cancers
title_full_unstemmed Metatranscriptome analysis in human papillomavirus negative cervical cancers
title_short Metatranscriptome analysis in human papillomavirus negative cervical cancers
title_sort metatranscriptome analysis in human papillomavirus negative cervical cancers
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445079/
https://www.ncbi.nlm.nih.gov/pubmed/36064569
http://dx.doi.org/10.1038/s41598-022-19008-8
work_keys_str_mv AT ureagustinenrique metatranscriptomeanalysisinhumanpapillomavirusnegativecervicalcancers
AT laghedencamilla metatranscriptomeanalysisinhumanpapillomavirusnegativecervicalcancers
AT arroyomuhrlailasara metatranscriptomeanalysisinhumanpapillomavirusnegativecervicalcancers